Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07193069

Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Centre Hospitalier de Saint-Denis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.

Conditions

Timeline

Start date
2025-04-11
Primary completion
2026-04-11
Completion
2026-04-11
First posted
2025-09-25
Last updated
2025-09-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07193069. Inclusion in this directory is not an endorsement.

Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning (NCT07193069) · Clinical Trials Directory